Literature DB >> 6220714

Structural differences of heparan sulfates according to the tissue and species of origin.

C P Dietrich, H B Nader, A H Straus.   

Abstract

Some structural features of thirteen heparan sulfates isolated from different mammalian tissues and species are reported. Two N-acetylated disaccharides, one of then O-sulfated and two N-sulfated disaccharides, one of then 6-sulfated are formed from these compounds by the combined action of heparitinases I and II from Flavobacterium heparinum. The relative proportions of the four disaccharide units vary quite significantly among the thirteen heparan sulfates indicating that the structure of these polymers are tissue and species specific. Based on the frequency of appearance of each one of the disaccharides it was calculated that 10(36) types of heparan sulfates might theoretically be found. The possible role of these polyanions in cell-cell recognition is discussed in view of the present findings.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220714     DOI: 10.1016/0006-291x(83)91379-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Presence of a laminin-binding chondroitin sulfate proteoglycan at the cell surface of a human melanoma cell Mel-85.

Authors:  M C Elias; S S Veiga; W Gremski; M A Porcionatto; H B Nader; R R Brentani
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer.

Authors:  Biao Han; Jian Liu; Min-Jie Ma; Lin Zhao
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 4.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.

Authors:  H B Nader; E Y Kobayashi; S F Chavante; I L Tersariol; R A Castro; S K Shinjo; A Naggi; G Torri; B Casu; C P Dietrich
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

6.  Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.

Authors:  Anastasia V Suhovskih; Natalya V Domanitskaya; Alexandra Y Tsidulko; Tatiana Y Prudnikova; Vladimir I Kashuba; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

7.  Host cell heparan sulfate proteoglycans mediate attachment and entry of Listeria monocytogenes, and the listerial surface protein ActA is involved in heparan sulfate receptor recognition.

Authors:  C Alvarez-Domínguez; J A Vázquez-Boland; E Carrasco-Marín; P López-Mato; F Leyva-Cobián
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

8.  Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.

Authors:  A G Gambarini; C A Miyamoto; G A Lima; H B Nader; C P Dietrich
Journal:  Mol Cell Biochem       Date:  1993-07-21       Impact factor: 3.396

9.  Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure.

Authors:  Carla Cerqueira; Yan Liu; Lena Kühling; Wengang Chai; Wali Hafezi; Toin H van Kuppevelt; Joachim E Kühn; Ten Feizi; Mario Schelhaas
Journal:  Cell Microbiol       Date:  2013-05-06       Impact factor: 3.715

10.  Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.

Authors:  H B Nader; C P Dietrich; V Buonassisi; P Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.